- Review Articles
- Genetics and Metabolism
- Development of orphan drugs for rare diseases
- Han-Wook Yoo
- Clin Exp Pediatr. 2024;67(7):315-327. Published online June 28, 2023
-
· Orphan disease is a rare disease, primarily affecting newborn and children. Vast majority of orphan diseases has genetic background.
· Orphan disease is individually rare. But as a whole, it is not rare, becoming a great socioeconomic burden.
· The diagnosis of rare genetic disease has been problematic, but recent progress of genome analysis technologies makes it faster and more precise.
· There are many unmet needs as to the curative treatment. However, the number of treatable rare diseases is growingly increasing owing to the development of biotechnology.
· Most orphan drugs are extremely expensive because of numer ous hurdles during the process of drug development as well as small number of patients.
- Endocrinology
- Association between pre- and postnatal exposure to endocrine-disrupting chemicals and birth and neurodevelopmental outcomes: an extensive review
- Ozge Yesildemir, Mensure Nur Celik
- Clin Exp Pediatr. 2024;67(7):328-346. Published online November 16, 2023
-
· Sensitivity to endocrine-disrupting chemical (EDC) exposure increases during critical developmental periods (in embryos, fetuses, and neonates).
· Pre- and postnatal exposure to EDCs is associated with fetal growth restriction, preterm birth, and low birth weight.
· Exposure to EDCs during fetal and early postnatal life can have lasting and lifelong neurodevelopmental outcomes, including autism spectrum, attention deficit hyperactivity, and other cognitive and behavioral disorders.
- General Pediatrics
- Metabolic complications of obesity in children and adolescents
- Hyunjin Park, Jung Eun Choi, Seunghee Jun, Hyelim Lee, Hae Soon Kim, Hye Ah Lee, Hyesook Park
- Clin Exp Pediatr. 2024;67(7):347-355. Published online November 16, 2023
-
· Pediatric obesity increases the risk of metabolic complications (insulin resistance, dyslipidemia, nonalcoholic fatty liver disease) and long-term cardiovascular diseases.
· A new obesity definition and various indicators (continuous metabolic syndrome score, pediatric simple metabolic syndrome score, fatty liver index) have been proposed to evaluate children’s susceptibility to metabolic disorders.
· Laboratory and body composition tests in pediatric screenings can identify groups at high risk of metabolic complications of obesity.
- Editorial
- Genetics and Metabolism
- Advancing orphan drug development for rare diseases
- Jung Min Ko
- Clin Exp Pediatr. 2024;67(7):356-357. Published online November 17, 2023
-
· Rare diseases present unique challenges and unmet needs for which the development of orphan drugs tailored to them offers hope.
· Despite the hurdles posed by limited patient populations, orphan drug designations from regulatory agencies provide incentives, such as extended market exclusivity and tax credits, that ignite transformative advances.
· Scientific progress in genomics, personalized medicine, and analytics empowers precise interventions by decoding genetic anomalies and encouraging effective treatments.
- Original Article
- Nutrition
- Parental support and exclusive breastfeeding at 3 months in West Java, Indonesia: a mixed-methods approach
- Ratu Ayu Dewi Sartika, Fadila Wirawan, Wawan Gunawan, Primasti Nuryandari Putri, Nurul Husna Mohd Shukri
- Clin Exp Pediatr. 2024;67(7):358-367. Published online June 21, 2024
-
Question: Does paternal support affect exclusive breastfeeding failure?
Finding: Exclusive breastfeeding failure by 3 months was affected by paternal support.
Meaning: Fathers should be included in breastfeeding education and antenatal care.
- Letter to the Editor
- Developmental and Behavioral Medicine
- Efficacy of social skills group intervention among children with mild autism spectrum disorder
- Lee Ling Low, Ker Yang Chua, Bih Hwa Ching
- Clin Exp Pediatr. 2024;67(7):368-370. Published online May 31, 2024
-
